A61K 49/124
Dendrimers, dendrons, hyperbranched compounds
Official title: {dendrimers, dendrons, hyperbranched compounds}
A61K49/124 (Dendrimers, dendrons, hyperbranched compounds) appears on 100 US grants and 108 published applications in this corpus.
Search patents in A61K- Granted patents
- 100
- Published applications
- 108
- Assignees
- 84
- Inventors
- 316
- Latest grant
- 17 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 4 | 0 |
| 2000 | 7 | 0 |
| 2001 | 6 | 1 |
| 2002 | 1 | 5 |
| 2003 | 3 | 3 |
| 2004 | 1 | 3 |
| 2005 | 4 | 7 |
| 2006 | 1 | 6 |
| 2007 | 4 | 7 |
| 2008 | 4 | 4 |
| 2009 | 0 | 6 |
| 2010 | 1 | 11 |
| 2011 | 4 | 4 |
| 2012 | 7 | 4 |
| 2013 | 5 | 4 |
| 2014 | 4 | 6 |
| 2015 | 7 | 5 |
| 2016 | 5 | 5 |
| 2017 | 6 | 2 |
| 2018 | 0 | 3 |
| 2019 | 2 | 3 |
| 2020 | 3 | 4 |
| 2021 | 4 | 5 |
| 2022 | 2 | 4 |
| 2023 | 3 | 0 |
| 2024 | 1 | 2 |
| 2025 | 2 | 2 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Radiolabeled ligands for targeted PET/SPECT imaging and methods of their use17 Feb 2026US 12,551,583 B2Memorial Sloan Kettering Cancer Center
- Compounds for use as iron(III) MRI contrast agents27 Jan 2026US 12,534,487 B2The Research Foundation for The State University of New York
- Formulation of contrast media and process of preparation thereof20 May 2025US 12,303,573 B2Bayer Aktiengesellschaft
- Pharmaceutical compositions comprising Gd-complexes and polyarylene additives18 Feb 2025US 12,226,494 B2Bracco Imaging S.P.A.
- Formulation of contrast media and process of preparation thereof2 Apr 2024US 11,944,690 B2Bayer Aktiengesellschaft
- Peptide multimer products and methods27 Aug 2026US 2026/0248969 A1The Regents of the University of Michigan
- Process Or The Preparation Of A Gadolinium Contrast Agent15 Jan 2026US 2026/0015331 A1
- Globular nanostructures12 Jun 2025US 2025/0186629 A1Spago Nanomedical AB
- Formulation of contrast media and process of preparation thereof15 May 2025US 2025/0152753 A1Bayer Aktiengesellschaft
- Formulation of contrast media and process of preparation thereof1 Aug 2024US 2024/0252690 A1Bayer Aktiengesellschaft
Most cited
By later US patents
- Bioactive and/or targeted dendrimer conjugates232US 5,714,166 ADendritech, Inc. · 1998
- Metal complexes derivatized with folate for use in diagnostic and therapeutic applications84US 6,093,382 ABracco Research USA · 2000
- System of drug delivery to the lymphatic tissues55US 5,582,172 AThe General Hospital Corporation · 1996
- Cascade polymer complexes, process for their production and pharamceutical agents containing said complexes48US 5,820,849 ASchering Corporation · 1998
- Phthalamide lanthanide complexes for use as luminescent markers48US 6,515,113 B2The Regents of the University of California · 2003